1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

Biosimilars | United States | Boehringer Ingelheim Pharmaceuticals Inc

Boehringer Ingelheim Pharmaceuticals Inc Us

Back

Download Excel File

Show entries

Search:

Approval Date	Ref Product Proper Name	Ref Product Proprietary Name	Biosimilar Name	Brand Name	Strength	Dosage Form	BLA Type	Manufacturer Name	Applicant Country	BLA Number	License Number	First Interchangeable Exclusivity Exp Date

Approval Date	Ref Product Proper Name	Ref Product Proprietary Name	Biosimilar Name	Brand Name	Strength	Dosage Form	BLA Type	Manufacturer Name	Applicant Country	BLA Number	License Number	First Interchangeable Exclusivity Exp Date
2017-08-25	Adalimumab	HUMIRA	Adalimumab-Adbm	CYLTEZO	40Mg/0.8Ml	Injection	351(K) Interchangeable	Boehringer Ingelheim Pharmaceuticals Inc	United States	761058	2006	2023-04-15

Showing 1 to 10 of 10 entries (filtered from 13 total entries)

Previous1Next

Boehringer Ingelheim Pharmaceuticals Inc Us

Advance Filter

Last Update : 2015 To Dec 2024